Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma
Authors:
Open Access
- 2 December 2013
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 33 (50) , 5706-5715
Abstract
Efforts to model human pancreatic neuroendocrine tumors (PanNETs) in animals have been moderately successful, with minimal evidence for glucagonomas or metastatic spread. The renin gene, although classically associated with expression in the kidney, is also expressed in many other extrarenal tissues including the pancreas. To induce tumorigenesis within rennin-specific tissues, floxed alleles of p53 and Rb were selectively abrogated using Cre-recombinase driven by the renin promoter. The primary neoplasm generated is a highly metastatic islet cell carcinoma of the pancreas. Lineage tracing identifies descendants of renin-expressing cells as pancreatic alpha cells despite a lack of active renin expression in the mature pancreas. Both primary and metastatic tumors express high levels of glucagon; furthermore, an increased level of glucagon is found in the serum, identifying the pancreatic cancer as a functional glucagonoma. This new model is highly penetrant and exhibits robust frequency of metastases to the lymph nodes and the liver, mimicking human disease, and provides a useful platform for better understanding pancreatic endocrine differentiation and development, as well as islet cell carcinogenesis. The use of fluorescent reporters for lineage tracing of the cells contributing to disease initiation and progression provides an unique opportunity to dissect the timeline of disease, examining mechanisms of the metastatic process, as well as recovering primary and metastatic cells for identifying cooperating mutations that are necessary for progression of disease.Keywords
This publication has 52 references indexed in Scilit:
- Intestinal Crypt Homeostasis Results from Neutral Competition between Symmetrically Dividing Lgr5 Stem CellsCell, 2010
- Multiple Endocrine Neoplasia Type 1 Deletion in Pancreatic α-Cells Leads to Development of Insulinomas in MiceEndocrinology, 2010
- α Cell–Specific Men1 Ablation Triggers the Transdifferentiation of Glucagon-Expressing Cells and Insulinoma DevelopmentGastroenterology, 2010
- Gene Amplifications in Well-Differentiated Pancreatic Neuroendocrine Tumors Inactivate the p53 PathwayGenes & Cancer, 2010
- Pancreatic neurogenin 3-expressing cells are unipotent islet precursorsDevelopment, 2009
- Deciphering von Hippel-Lindau (VHL/Vhl)-Associated Pancreatic Manifestations by Inactivating Vhl in Specific Pancreatic Cell PopulationsPLOS ONE, 2009
- In vivo analysis of key elements within the renin regulatory regionPhysiological Genomics, 2008
- Histone Deacetylase Inhibitors Modify Pancreatic Cell Fate Determination and Amplify Endocrine ProgenitorsMolecular and Cellular Biology, 2008
- The physiology of a local renin–angiotensin system in the pancreasThe Journal of Physiology, 2007
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996